Q3 2015 Newsletter (Issue 11) now available

In this issue:

  • We announce the continued expansion of the BIONET portfolio with co-marketing agreements with Cancer Research Technology (Ximbio) and Liverpool ChiroChem
  • BIONET releases New 5-trifluoromethyl-2,3-disubstituted pyridines
  • Describes how Key Organics has synthesised Risperidone-d4 and how we can help with your Isotope Labelled Compound requirements
  • Features the 2nd Generation BIONET Premium Fragment Library which is now available
  • DABAL-Me3 – a versatile tool for modern chemistry and now part of the BIONET collection
  • Profile our event attendance at conferences and exhibitions this quarter

Click here to download the PDF

Latest News

POA Enquiry Form

We aim to give you a response from a qualified scientist within a hour

Enquire about pack size

Please specify your custom pack size below